Idera Home Page
Home| Site Map| Contact| Careers
    • Letter to Shareholders
    • Management Team
    • Board of Directors
    • Advisory Boards
    • Corporate Governance
    • Careers
    • Oncology
    • Infectious Diseases
    • Autoimmune Diseases
    • Respiratory Diseases
    • Vaccine Adjuvants
    • Agonists
    • Antagonists
    • Scientific Publications
    • Intellectual Property
    • Novartis International Pharmaceutical, Ltd.
    • Merck & Co., Inc.
    • Merck KGaA
    • Overview
    • Corporate Governance
    • Stock Information
    • Financial Reports
    • SEC Filings
    • Event Calender
    • Webcasts
    • Presentations
    • News
    • FAQ
    • Analyst Coverage
    • Information Request
    • E-mail Alerts
    • Investor Contact
    About Idera
  • Letter to Stockholders
  • Management Team
  • Board of Directors
  • Advisory Boards
  • Corporate Governance
  • Careers
About Idera » Board of Directors

Board of Directors

James B. Wyngaarden, M.D. ׀ Chairman of the Board of Directors
Youssef El Zein ׀ Vice Chairman of the Board of Directors
Sudhir Agrawal, D. Phil. ׀ Director
Robert W. Karr, M.D. ׀ Director
C. Keith Hartley ׀ Director
Hans Mueller, Ph.D. ׀ Director
William S. Reardon, C.P.A. ׀ Director
Alison Taunton-Rigby, Ph.D., OBE ׀ Director
Paul C. Zamecnik, M.D. ׀ Director Emeritus


Idera Pharmaceuticals, Inc., ©2008 - All Rights Reserved. Terms of Use
About Idera| Pipeline| TLR Technology| Partners| Investors| Collaborators| Site Map| Contact| Careers